MiMedx Group (MDXG) Expected to Announce Earnings on Wednesday

MiMedx Group (NASDAQ:MDXG) is projected to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect MiMedx Group to post earnings of $0.07 per share and revenue of $89.42 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

MiMedx Group Price Performance

NASDAQ MDXG opened at $7.98 on Monday. The company has a 50-day moving average price of $8.84 and a 200-day moving average price of $7.66. MiMedx Group has a 52 week low of $5.47 and a 52 week high of $10.14. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $1.17 billion, a P/E ratio of 14.51 and a beta of 1.94.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 8th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.